Search Database

Name

Cabazitaxel

Alternate Names

Jevtana
XRP-6258

Abbreviations

None

Category

Chemotherapy

Subcategory

Microtubule inhibitor

NSC Number

None

Primary Site

Prostate

Histology

None

Remarks

FDA approved June 17, 2010 for treatment of hormone-refractory prostate cancer.

Coding

This drug should be coded
Glossary